Three-high danshu capsule and production and preparation process thereof

Abstract

The invention relates to a three-high danshu capsule and a preparation process thereof. The three-high danshu capsule is characterized by comprising the following components in parts by weight: 10-20 parts of hawthorn, 8-15 parts of prepared multiflower knotweed root, 5-10 parts of cassia seed, 5-10 parts of rhizoma alismatis, 3-8 parts of ginseng, 3-8 parts of bulbus allii macrostemi and 5-10 parts of radix salviae miltiorrhizae; the preparation process comprises the following steps: (1) extracting the ginseng, the bulbus allii macrostemi and the radix salviae miltiorrhizae by ethanol, filtering an extract, recovering the ethanol from filtrate, decompressing and concentrating; (2) after extracting by the ethanol, adding water into the medicine residues of the ginseng, the bulbus allii macrostemi and the radix salviae miltiorrhizae, the hawthorn, prepared multiflower knotweed root, the cassia seed and the rhizoma alismatis, extracting, filtering, decompressing and concentrating the filtrate; (3) after concentrating, merging the ethanol extract and the water extract and concentrating continuously; (4) drying the extract in vacuum, pulverizing, sieving and storing dry powder after pulverizing for later use; (5) adding the auxiliary materials of talcum powder and magnesium stearate with a conventional quantity into the obtained extract powder and mixing; and (6) preparing the capsule. Experiments show that the three-high danshu capsule has a better health-care function of regulating blood fat and has no adverse reaction.

Description

(1) Field of invention: [0001] The invention belongs to the field of health food, and relates to a health product capsule and a production process thereof, in particular to a Sangao Danshu capsule and a production process thereof. (two) background technology: [0002] In 2002, the "Nutrition and Health Survey of Chinese Residents" conducted nationwide by the Ministry of Health (also the largest epidemiological survey of blood lipids in my country so far) showed that the total prevalence of dyslipidemia among people aged 18 and over in my country was 18.6%. , 22.2% for men and 15.9% for women. Based on this calculation, it is estimated that there are 160 million patients with dyslipidemia aged ≥18 in the country, 21.0% of the urban population and 17.7% of the rural population. The epidemiological characteristics of dyslipidemia are mainly as follows: (1) The prevalence rate of men is higher than that of women, and it increases with age. According to the national survey in 200...

AI Technical Summary

Problems solved by technology

[0003] At present, there are many products that focus on and treat hyperlipidemia. For hyperlipidemia, Western medicine has a more significant effect, but it is expensive and has obvious side effects after long-term use; there are many traditional Chinese medicine compound prescriptions for treating hyperlipidemia, but some It belongs to treating the symptoms but not the root cause, some use expensive ingredients, and some discontinue use due to poor adjuvant treatment effect during use

Images